Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-10

Clinical Trial Update: Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients

View source ↗

Summary

This clinical trial investigates irisin hormone as a diagnostic marker for detecting and monitoring the progression of diabetic nephropathy. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sohag University | Conditions: Diabetic Nephropathies | Status: NOT_YET_RECRUITING